[Decrease in blood pressure after parenteral trial doses of reserpine (serpasil), hydralazine (apresolin), and pentapyrrolidin (ansolysen) in patients with arterial hypertension, with special reference to the value of the test as an indicator of the clinical effect in subsequent peroral prolonged treatment].
D000368:Aged; D001794:Blood Pressure; D001795:Blood Pressure Determination; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010425:Pentolinium Tartrate; D012110:Reserpine / Q000627:therapeutic use*
D009125:Muscle Relaxants, Central; D006830:Hydralazine; D012110:Reserpine; D010425:Pentolinium Tartrate
HYDRALAZINE/therapeutic use; HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; RESERPINE/therapeutic use
Blodtryksfaldet efter parenterale provedoser reserpin (serpasil), hydralazin (apresolin) og pentapyrrolidin (ansolysen) hos patienter med hypertensio arterialis, med saerligt henblik pa reaktionens vaerdi som rettesnor for behandlingen.